118 related articles for article (PubMed ID: 23230145)
21. Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity.
McPherson JP; Tamblyn L; Elia A; Migon E; Shehabeldin A; Matysiak-Zablocki E; Lemmers B; Salmena L; Hakem A; Fish J; Kassam F; Squire J; Bruneau BG; Hande MP; Hakem R
EMBO J; 2004 Sep; 23(18):3677-88. PubMed ID: 15343267
[TBL] [Abstract][Full Text] [Related]
22. The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway.
Furth N; Aylon Y
Cell Death Differ; 2017 Sep; 24(9):1488-1501. PubMed ID: 28644436
[TBL] [Abstract][Full Text] [Related]
23. LATS1/2 control TGFB-directed epithelial-to-mesenchymal transition in the murine dorsal cranial neuroepithelium through YAP regulation.
Martínez Traverso IM; Steimle JD; Zhao X; Wang J; Martin JF
Development; 2022 Sep; 149(18):. PubMed ID: 36125128
[TBL] [Abstract][Full Text] [Related]
24. SUMOylation of large tumor suppressor 1 at Lys751 attenuates its kinase activity and tumor-suppressor functions.
Mei L; Yuan L; Shi W; Fan S; Tang C; Fan X; Yang W; Qian Y; Hussain M; Wu X
Cancer Lett; 2017 Feb; 386():1-11. PubMed ID: 27847303
[TBL] [Abstract][Full Text] [Related]
25. Hippo pathway deletion in adult resting cardiac fibroblasts initiates a cell state transition with spontaneous and self-sustaining fibrosis.
Xiao Y; Hill MC; Li L; Deshmukh V; Martin TJ; Wang J; Martin JF
Genes Dev; 2019 Nov; 33(21-22):1491-1505. PubMed ID: 31558567
[TBL] [Abstract][Full Text] [Related]
26. HIPK2 deficiency causes chromosomal instability by cytokinesis failure and increases tumorigenicity.
Valente D; Bossi G; Moncada A; Tornincasa M; Indelicato S; Piscuoglio S; Karamitopoulou ED; Bartolazzi A; Pierantoni GM; Fusco A; Soddu S; Rinaldo C
Oncotarget; 2015 Apr; 6(12):10320-34. PubMed ID: 25868975
[TBL] [Abstract][Full Text] [Related]
27. The Hippo pathway effector YAP is an essential regulator of ductal progenitor patterning in the mouse submandibular gland.
Szymaniak AD; Mi R; McCarthy SE; Gower AC; Reynolds TL; Mingueneau M; Kukuruzinska M; Varelas X
Elife; 2017 May; 6():. PubMed ID: 28492365
[TBL] [Abstract][Full Text] [Related]
28. [Under-expression of LATS1 promotes the differentiation, proliferation and migration of mesenchymal stem cells by inhibition the Hippo signaling pathway in vitro].
Li L; Dong L; Hui J; Gao F; Wang Q; Yang L; Zhang J; Yan J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Aug; 29(8):731-737. PubMed ID: 28795673
[TBL] [Abstract][Full Text] [Related]
29. LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function.
Tang F; Gao R; Jeevan-Raj B; Wyss CB; Kalathur RKR; Piscuoglio S; Ng CKY; Hindupur SK; Nuciforo S; Dazert E; Bock T; Song S; Buechel D; Morini MF; Hergovich A; Matthias P; Lim DS; Terracciano LM; Heim MH; Hall MN; Christofori G
Nat Commun; 2019 Dec; 10(1):5755. PubMed ID: 31848340
[TBL] [Abstract][Full Text] [Related]
30. Zyxin-Siah2-Lats2 axis mediates cooperation between Hippo and TGF-β signalling pathways.
Ma B; Cheng H; Gao R; Mu C; Chen L; Wu S; Chen Q; Zhu Y
Nat Commun; 2016 Mar; 7():11123. PubMed ID: 27030211
[TBL] [Abstract][Full Text] [Related]
31. LATS1 Is a Mediator of Melanogenesis in Response to Oxidative Stress and Regulator of Melanoma Growth.
Kazimierczak U; Dondajewska E; Zajaczkowska M; Karwacka M; Kolenda T; Mackiewicz A
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803640
[TBL] [Abstract][Full Text] [Related]
32. miR-302/367/LATS2/YAP pathway is essential for prostate tumor-propagating cells and promotes the development of castration resistance.
Guo Y; Cui J; Ji Z; Cheng C; Zhang K; Zhang C; Chu M; Zhao Q; Yu Z; Zhang Y; Fang YX; Gao WQ; Zhu HH
Oncogene; 2017 Nov; 36(45):6336-6347. PubMed ID: 28745315
[TBL] [Abstract][Full Text] [Related]
33. Targeted Disruption of Lats1 and Lats2 in Mice Impairs Adrenal Cortex Development and Alters Adrenocortical Cell Fate.
Ménard A; Abou Nader N; Levasseur A; St-Jean G; Le Roy MLG; Boerboom D; Benoit-Biancamano MO; Boyer A
Endocrinology; 2020 May; 161(5):. PubMed ID: 32243503
[TBL] [Abstract][Full Text] [Related]
34. PRAMEF2-mediated dynamic regulation of YAP signaling promotes tumorigenesis.
Ghosh M; Das S
Proc Natl Acad Sci U S A; 2021 Oct; 118(40):. PubMed ID: 34593639
[TBL] [Abstract][Full Text] [Related]
35. The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity.
Moroishi T; Hayashi T; Pan WW; Fujita Y; Holt MV; Qin J; Carson DA; Guan KL
Cell; 2016 Dec; 167(6):1525-1539.e17. PubMed ID: 27912060
[TBL] [Abstract][Full Text] [Related]
36. T851I mutation of human large tumor suppressor 1 disrupts its kinase activity and tumor-suppressor functions.
Zhang Q; Du X; He Q; Shi W; Mei L; Qv M; Tan D; Wu J; Zeng LH; Wu X
Life Sci; 2021 Jan; 264():118655. PubMed ID: 33141042
[TBL] [Abstract][Full Text] [Related]
37. NUAK2 is a critical YAP target in liver cancer.
Yuan WC; Pepe-Mooney B; Galli GG; Dill MT; Huang HT; Hao M; Wang Y; Liang H; Calogero RA; Camargo FD
Nat Commun; 2018 Nov; 9(1):4834. PubMed ID: 30446657
[TBL] [Abstract][Full Text] [Related]
38. The NDR/LATS protein kinases in immunology and cancer biology.
Sharif AAD; Hergovich A
Semin Cancer Biol; 2018 Feb; 48():104-114. PubMed ID: 28579171
[TBL] [Abstract][Full Text] [Related]
39. Two faces of Hippo: activate or suppress the Hippo pathway in cancer.
Cao J; Huang W
Anticancer Drugs; 2017 Nov; 28(10):1079-1085. PubMed ID: 28926422
[TBL] [Abstract][Full Text] [Related]
40. Lats1 Deletion Causes Increased Germ Cell Apoptosis and Follicular Cysts in Mouse Ovaries.
Sun T; Pepling ME; Diaz FJ
Biol Reprod; 2015 Jul; 93(1):22. PubMed ID: 26040669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
